• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Endocrinol Invest . Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy

tetano

Editor, Senior Moderator
J Endocrinol Invest


. 2020 Aug 10.
doi: 10.1007/s40618-020-01382-7. Online ahead of print.
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy


S Ciardullo[SUP] 1 2 [/SUP], F Zerbini[SUP] 2 [/SUP], S Perra[SUP] 2 [/SUP], E Muraca[SUP] 2 [/SUP], R Cannistraci[SUP] 1 2 [/SUP], M Lauriola[SUP] 2 [/SUP], P Grosso[SUP] 3 [/SUP], G Lattuada[SUP] 2 [/SUP], G Ippoliti[SUP] 2 [/SUP], A Mortara[SUP] 4 [/SUP], G Manzoni[SUP] 2 [/SUP], G Perseghin[SUP] 5 6 [/SUP]



Affiliations

Abstract

Purpose: The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19).
Methods: This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables.
Results: Mean age of the patients was 72 ? 14 years (range 17-98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Relative Risk [RR] 1.06 [1.04-1. 09] per year), diabetes (RR 1.56 [1.05-2.02]), chronic obstructive pulmonary disease (RR 1.82 [1.13-2.35]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality.
Conclusion: In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.

Keywords: COVID-19; Coronavirus; Diabetes; Mortality; SARS-CoV-2.
 
Back
Top Bottom